Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05736133
Other study ID # 6038205
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 2, 2023
Est. completion date February 16, 2025

Study information

Verified date April 2024
Source Queen's University
Contact Jordan Miller, PhD
Phone 905-872-9938
Email jordan.miller@queensu.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a pilot cluster randomized controlled trial to to evaluate the individual and health system impacts of implementing a new physiotherapist-led primary care model for hip and knee pain in Canada.


Description:

Arthritis is one of the leading causes of pain, disability, and reduced quality of life in patients. Arthritis currently affects one in five Canadians (six million), which is expected to rise to nine million people by 2040. Osteoarthritis (OA) is the most common forms of arthritis, with hip and knee being two of the most common locations. For most people, the first point of contact for their pain is their primary care provider. Due to the rise in patients seeking support at the primary care level, the shortage of primary care providers, and the high burden on these providers, patients often do not receive timely access to the care they require. A promising strategy is to have an integrated model of care where a physiotherapist (PT) is the first point of contact within interprofessional primary care teams. PTs can provide a comprehensive and efficient management strategy for patients presenting to their primary care provider with hip and knee pain complaints. This study aims to determine the feasibility of conducting a cluster randomized trial in primary care settings in Ontario to evaluate the individual health outcomes and health system impact of implementing a new physiotherapist-led primary care model for people with hip and knee pain. The primary objectives of this pilot study are: 1. Determine the feasibility of participant recruitment, assessment procedures, and retention. 2. Determine the feasibility of implementing a new PT led primary care model for hip and knee pain. 3. Explore the perspectives of patient participants and HCPs related to their experiences and attitudes towards the new service delivery model, barriers/facilitators to implementation, perceived satisfaction, perceived value and impact on clinic processes and patient participant outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 263
Est. completion date February 16, 2025
Est. primary completion date February 16, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: - Adults >= 19 years who ask to book a primary care visits where the primary reason is for hip or knee pain of any duration. Exclusion Criteria: - Cannot understand, read, and write English - Known cancer causing hip or knee pain

Study Design


Intervention

Other:
Physiotherapist-led primary care model for hip and knee pain
Initial assessment and screening: The PT will provide a comprehensive assessment according to established clinical practice guidelines. Brief individualized intervention at first visit: The PT intervention will be at the discretion of the PT to reflect real-world PT intervention. Health services navigation: Participants will be provided with options available to them in their community for rehabilitation. For example, they may be referred to community PT for ongoing management or presented with group exercise options. Participants will be assessed regarding the need for specialist referrals or resources available to manage complex clinical presentations such as comorbidity or frailty. Participants may be referred to the primary care provider if no specialized services are needed or when the PT cannot provide a direct referral. All individuals may have their medications reviewed by a physician if deemed appropriate by the PT or requested by the participant.
Usual physician-led primary care model for hip and knee pain
The physician led primary care intervention will be unstandardized to best reflect standard clinical practice in Canada.

Locations

Country Name City State
Canada Queen's University Kingston Ontario

Sponsors (3)

Lead Sponsor Collaborator
Jordan Miller, PT, PhD Canadian Institutes of Health Research (CIHR), The Arthritis Society, Canada

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Baseline Characteristics To describe the study population, the investigators will capture the following through the survey: age, sex, gender, duration of musculoskeletal pain, locations of pain, medications, comorbidities, current work status, income, rurality, and ethnicity. Baseline
Other Comorbidities Measured at baseline using the Functional Comorbidity Index (an 18-item list of comorbidities that are associated with physical functioning). Baseline
Other Chronicity of Pain Self-reported length of time since current and first incidence of hip or knee pain Baseline
Other Participant Treatment Fidelity Self-report adherence to PT advice 3 months follow-up
Primary Participant Recruitment Rate A full trial will be feasible if the investigators are able to recruit 1.5 participants per week per site over 20 weeks 20 weeks
Primary Assessment Procedures The investigators consider =80% of all assessment items completed and a mean time for completion of =60 minutes acceptable. 12 months
Primary Retention The investigators consider an attrition rate of =20% at 12-month follow-up successful. =35% attrition will be considered partially successful; however, additional retention strategies would be required for the full trial based on evidence that =20% attrition threatens trial validity 12 months
Primary PT Treatment Fidelity Treatment fidelity will be measured through an audit of a PT fidelity checklist and electronic medical record (EMR) to determine the consistency of the care provided. An acceptable level of fidelity will be considered =80% for each intervention component. 20 weeks
Secondary Self-Reported Functioning Self-report using the Lower Extremity Functional Scale (0-80 score with higher score representing higher function) Baseline and 3, 6, 9, and 12 months follow-up
Secondary Self-Reported Pain Intensity Measured using a numeric pain rating scale from 0 to 10 with higher scores indicating greater pain intensity. Baseline and 3, 6, 9, and 12 months follow-up
Secondary Health-Related Quality of Life Measured using the EuroQoL-5D-5L (0 to 100 with greater scores indicating greater self-reported health related quality of life) Baseline and 3, 6, 9, and 12 months follow-up
Secondary Pain Self Efficacy Confidence in abilities to participate in usual activities using the Pain Self Efficacy Questionnaire Baseline and 3, 6, 9, and 12 months follow-up
Secondary Catastrophic Thinking Measured using the Pain Catastrophizing Scale (0 to 52 with higher scores indicating greater catastrophic thinking) Baseline and 3, 6, 9, and 12 months follow-up
Secondary Fear of Movement Measured using the Tampa Scale of Kinesiophobia (an 11-item questionnaire) Baseline and 3, 6, 9, and 12 months follow-up
Secondary Depression Subscale Measured using the 2-Item Patient Health Questionnaire Baseline and 3, 6, 9, and 12 months follow-up
Secondary Global Rating of Change Measured using an 11-point scale (-5 to +5 with negative scores indicating a worsening of physical functioning and positive scores indicating an improvement of physical functioning) 3, 6, 9, and 12 months follow-up
Secondary Satisfaction with Health Care Measured using an 11-point scale(-5 to +5 with negative scores indicating a dissatisfaction with health care received and positive scores indicating satisfaction with health care received) 3, 6, 9, and 12 months follow-up
Secondary Adverse Events Measured using an adverse events questionnaire that asks 1) if the participant has experienced any adverse events as a result of the treatments received (yes/no); 2) how long the event lasted (hours or days); 3) how severe the adverse event was (0-10 scale); 4) what adverse events were experienced. 3, 6, 9, and 12 months follow-up
Secondary Health Care Accessibility Percentage of participants assessed within 48 hours of calling for an appointment Baseline
Secondary Health-Care Utilization - Consultations in Electronic Medical Record (EMR) Number of consultations with primary care team members for hip or knee pain (e.g., physicians, nurse practitioners, nurses, social workers, occupational therapists) 12 months
Secondary Health-Care Utilization Survey - Visits to health professionals Survey questions related to hip or knee pain: number of visits to health professionals outside the primary care team (e.g., chiropractors, massage therapists, occupational therapists, physiotherapists, chronic pain clinics) 12 months
Secondary Health-Care Utilization Survey - Medications Survey questions related to hip or knee pain: number of medications taken. Includes type of medication, dose, frequency 12 months
Secondary Health-Care Utilization Survey - Walk-In Clinic Visits Survey questions related to hip or knee pain: number of walk-in clinic visits outside of primary care centre 12 months
Secondary Health-Care Utilization Survey - Emergency Department Visits Survey questions related to hip or knee pain: number of emergency department visits 12 months
Secondary Health-Care Utilization Survey - Inpatient Hospital Stays Survey questions related to hip or knee pain: number of overnight hospital stays 12 months
Secondary Health-Care Utilization Survey - Surgeries, Procedures, Injections Survey questions related to hip or knee pain: number of surgeries, procedures, and injections 12 months
Secondary Health-Care Utilization Survey - Specialist Visits Survey questions related to hip or knee pain: number of visits to specialists 12 months
Secondary Health-Care Utilization Survey - Diagnostic Imaging Survey questions related to hip or knee pain: number of diagnostic images received 12 months
Secondary Process Outcome - Medications Prescibed Collected from the EMR: medications prescribed for hip or knee pain. Includes the type of medication prescribed 12 months
Secondary Process Outcome - Diagnostic Imaging Ordered Collected from the EMR: diagnostic images ordered for hip or knee pain 12 months
Secondary Process Outcome - Exercises Prescribed Collected from the EMR: exercises prescribed for hip or knee pain 12 months
Secondary Process Outcome - Education Provided Collected from the EMR: education provided for hip or knee pain 12 months
Secondary Process Outcome - Referrals to other health care providers (HCPs) Collected from the EMR: referrals to other HCPs (both internal and external to the primary health care team) for hip or knee pain 12 months
Secondary Process Outcome - Primary Care Visits Collected from the EMR: visits to the primary care team for hip or knee pain 12 months
Secondary Process Outcome - Notes to Employers or Insurers Collected from the EMR: notes provided to employers or insurers for hip or knee pain 12 months
Secondary Self-Report Time Lost Self-reported time lost from work, volunteering, homemaking, and educational activities 12 months
Secondary Assistance Needed Self-reported assistance needed, due to hip or knee pain, for self-care, housework, shopping, or transportation 12 months
Secondary Extra Expenses Any extra expenses incurred as a result of hip or knee pain. Self-report 12 months
Secondary Cost Outcomes Costs associated with all health utilization, self-reported time lost, assistance needed, and extra expenses. Will be presented as aggregate and time-specific costs 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT04651673 - Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)
Completed NCT05677399 - Knee Osteoarthritis Treatment With Peloidotherapy and Aquatic Exercise. N/A
Active, not recruiting NCT04043819 - Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis Phase 1
Recruiting NCT06000410 - A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee Phase 3
Completed NCT05014542 - Needling Techniques for Knee Osteoarthritis N/A
Recruiting NCT05892133 - Prehabilitation Effect on Function and Patient Satisfaction Following Total Knee Arthroplasty N/A
Recruiting NCT05528965 - Parallel Versus Perpendicular Technique for Genicular Radiofrequency N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Active, not recruiting NCT02003976 - A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone N/A
Active, not recruiting NCT04017533 - Stability of Uncemented Medially Stabilized TKA N/A
Completed NCT04779164 - The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis N/A
Recruiting NCT04006314 - Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis N/A
Recruiting NCT05423587 - Genicular Artery Embolisation for Knee Osteoarthritis II N/A
Enrolling by invitation NCT04145401 - Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
Active, not recruiting NCT03781843 - Effects of Genicular Nerve Block in Knee Osteoarthritis N/A
Completed NCT05974501 - Pre vs Post Block in Total Knee Arthroplasty (TKA) Phase 4
Completed NCT05324163 - Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis Phase 3
Completed NCT05529914 - Effects of Myofascial Release and Neuromuscular Training for Pes Anserine Syndrome Associated With Knee Osteoarthritis N/A
Recruiting NCT05693493 - Can Proprioceptive Knee Brace Improve Functional Outcome Following TKA? N/A
Not yet recruiting NCT05510648 - Evaluation of the Effect of High-intensity Laser Therapy in Knee Osteoarthritis N/A